Key result
Acute ischemic stroke thrombolysis incurs hospital costs substantially exceeding average Medicare reimbursement.
Observational (n=63,472)
Yes
Answers are grounded in this paper and cite their sources.
BACKGROUND AND PURPOSE: It is important to know the costs for hospitalization for ischemic stroke patients treated with intravenous thrombolysis so that comparisons can be made with payments to hospitals. METHODS: Using the National Inpatient Sample, we evaluated hospitalization costs for patients treated with intravenous thrombolysis for acute ischemic stroke in the United States from 2001 to 2008. Cost data were correlated with demographics and clinical outcome. RESULTS: Intravenous thrombolysis for acute ischemic stroke was received by 63 472 patients; 24 094 patients were younger than age 65 years and 40 780 patients were 65 years or older. Median hospital costs in 2008 dollars were $14 102 (interquartile range, $9987-$20 819) for patients with good outcome, $18 856 (interquartile range, $13 145-$30 423) for patients with severe disability, and $19 129 (interquartile range, $11 966-$30 781) for patients with in-hospital mortality. Average 2008 Medicare payments were $10 098 for intravenous thrombolysis without complication and $13 835 for intravenous thrombolysis with major complication. CONCLUSIONS: Hospitalization costs for patients treated with intravenous thrombolysis are substantially higher than Medicare payments.
No takes yet. Share an insight, caveat, or question.
Brinjikji et al. (2011) conducted an observational in Acute ischemic stroke (n=63,472). Intravenous thrombolysis vs. Medicare payments was evaluated on Hospitalization costs in 2008 dollars. Intravenous thrombolysis for acute ischemic stroke had median hospital costs ($14,102-$19,129) substantially higher than average Medicare payments ($10,098-$13,835).
Synapse has enriched 5 related papers. Consider them for comparative context: